Valirx Plc

ValiRx PLC is a British biotechnology company focused on developing novel cancer therapies. Its primary aim is to advance innovative drug candidates through preclinical and clinical development phases. The company's operations centre around creating targeted treatments for various forms of cancer. Operating within the pharmaceutical and biotechnology sector, ValiRx PLC specifically focuses on therapies that selectively target cancer cells while sparing healthy tissue. The intended outcome of its work is to provide more effective and less toxic treatment options for patients with significant unmet medical needs. Track the share price of VAL.L by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.